drugset / Trial / NCT03768492

Study of the Safety and Efficacy of a Caffeine-based Antifibrosis Cream in Patients With Breast Cancer Undergoing Radiation Therapy

NCT03768492

Phase 2 Active not recruiting 60 enrolled NYU Langone Health
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate whether a caffeine-based cream can reduce the rates of reconstructive complications in patients with tissue expander based reconstruction requiring post-mastectomy radiation therapy when compared to a placebo cream.

Timeline

Start
2020-06-29
Primary completion
2027-12
Completion
2027-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 5 %

Indications